Note 11 - Accrued Expenses

9 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

11. Accrued Expenses

Accrued expenses consist of the following:

	September 30,		December 31,
	2019		2018
Compensation and related expenses	$	4,039	$	4,446
Professional fees		1,333		1,989
Operating lease liability - current		1,109		-
Income taxes payable		766		385
Research grants		381		400
Clinical trial costs		497		577
Other		368		349
Total	$	8,493	$	8,146

The lease liability as of

September 30, 2019

is the result of the Company adopting ASU

2016

-

02

as of

January 1, 2019

as more fully described in Note

12.